跳至主要内容
临床试验/NCT02550782
NCT02550782已完成不适用

Does Patient-Controlled Infraclavicular Perineural Dexmedetomidine Improve Postoperative Analgesia Deadline?

Cukurova University1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2015年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
60
试验地点
1
主要终点
visual analog scale

研究概览

简要总结

Infraclavicular block is one of the peripheral nerve block used in upper extremity surgery. Adjuvant agents are used in peripheral nerve blocks to increase the duration and block quality. We investigated that the effects of patient-controlled perineural dexmedetomidine application on postoperative analgesia.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • be undergoing distal upper extremity surgery
  • Be between 18-65 years
  • to agree to participate in research

排除标准

  • allergy to dexmedetomidine
  • AV block or bradycardia
  • being serious cardiac - liver - kidney function disorders
  • Being coagulopathy
  • neuropathy in the upper extremity
  • adrenoceptor agonists or antagonists use

研究组 & 干预措施

perineural bupivacaine

Active Comparator

patient-controlled infraclavicular perineural bupivacaine

(1% bupivacaine (marcaine), 5 ml bolus dose, infusion rate of 5 ml / h, lockout time 1 hour)

干预措施: Bupivacaine (Drug)

perineural bupivacaine

Active Comparator

patient-controlled infraclavicular perineural bupivacaine

(1% bupivacaine (marcaine), 5 ml bolus dose, infusion rate of 5 ml / h, lockout time 1 hour)

干预措施: Dexmedetomidine (Drug)

perineural dexmedetomidine

Experimental

patient-controlled infraclavicular perineural dexmedetomidine

(1% bupivacaine + 200 mic / 100cc dexmedetomidine, 5 ml bolus dose, infusion rate of 5 ml / h, lockout time 1 hour)

干预措施: Bupivacaine (Drug)

perineural dexmedetomidine

Experimental

patient-controlled infraclavicular perineural dexmedetomidine

(1% bupivacaine + 200 mic / 100cc dexmedetomidine, 5 ml bolus dose, infusion rate of 5 ml / h, lockout time 1 hour)

干预措施: Dexmedetomidine (Drug)

结局指标

主要结局

visual analog scale

时间窗: 3 month

Scores range from 0 \[no pain\] to 10 \[worst possible pain

次要结局

  • The effect of dexmedetomidine to the Ramsey Sedation Scale(3 month)
  • side effects(3 month)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

ILKE KUPELI

Anaesthesiology and reanimation

Cukurova University

研究点 (1)

Loading locations...

相似试验